StockData

Aspira Women's Health Inc. (AWHL) stock

AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.22−0.01 (-2.61%)

Close on Oct 19, 2026Market cap $9.91MP/E –Yield –

Aspira Women's Health operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Aspira Women's Health's operating cash flow for the twelve months ending Jun 30, 2026 was -$4.56M. For fiscal 2025 it was -$7.03M. The highest annual figure on record is -$7.03M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$7.03M–
FY2024Dec 31, 2024-$12.11M–
FY2023Dec 31, 2023-$15.89M–
FY2022Dec 31, 2022-$31.07M–
FY2021Dec 31, 2021-$27.40M–
FY2020Dec 31, 2020-$14.73M–
FY2019Dec 31, 2019-$12.97M–
FY2018Dec 31, 2018-$9.37M–
FY2017Dec 31, 2017-$8.13M–
FY2016Dec 31, 2016-$13.96M–
FY2015Dec 31, 2015-$18.37M–
FY2014Dec 31, 2014-$16.81M–
FY2013Dec 31, 2013-$8.22M–
FY2012Dec 31, 2012-$10.40M–
FY2011Dec 31, 2011-$15.58M–
FY2010Dec 31, 2010-$20.94M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.01M–
Q1 FY2026Mar 31, 2026-$359.00K–
Q4 FY2025Dec 31, 2025-$1.98M–
Q3 FY2025Sep 30, 2025-$212.00K–
Q2 FY2025Jun 30, 2025-$1.73M–
Q1 FY2025Mar 31, 2025-$3.10M–
Q4 FY2024Dec 31, 2024-$1.02M–
Q3 FY2024Sep 30, 2024-$2.92M-187.9%
Q2 FY2024Jun 30, 2024-$3.74M-209.5%
Q1 FY2024Mar 31, 2024-$4.43M–
Q4 FY2023Dec 31, 2023-$3.45M–
Q3 FY2023Sep 30, 2023$3.32M–
Q2 FY2023Jun 30, 2023$3.42M–
Q1 FY2023Mar 31, 2023-$5.71M–
Q4 FY2022Dec 31, 2022-$7.08M–
Q3 FY2022Sep 30, 2022-$7.52M–
Q2 FY2022Jun 30, 2022-$6.30M–
Q1 FY2022Mar 31, 2022-$10.17M–
Q4 FY2021Dec 31, 2021-$7.65M–
Q3 FY2021Sep 30, 2021-$8.00M–
Q2 FY2021Jun 30, 2021-$6.49M–
Q1 FY2021Mar 31, 2021-$5.26M–
Q4 FY2020Dec 31, 2020-$4.76M–
Q3 FY2020Sep 30, 2020-$3.07M–
Q2 FY2020Jun 30, 2020-$3.41M–
Q1 FY2020Mar 31, 2020-$3.50M–
Q4 FY2019Dec 31, 2019-$2.87M–
Q3 FY2019Sep 30, 2019-$3.44M–
Q2 FY2019Jun 30, 2019-$3.54M–
Q1 FY2019Mar 31, 2019-$3.11M–
Q4 FY2018Dec 31, 2018-$2.30M–
Q3 FY2018Sep 30, 2018-$2.29M–
Q2 FY2018Jun 30, 2018-$2.42M–
Q1 FY2018Mar 31, 2018-$2.36M–
Q4 FY2017Dec 31, 2017-$2.15M–
Q3 FY2017Sep 30, 2017-$1.79M–
Q2 FY2017Jun 30, 2017-$1.77M–
Q1 FY2017Mar 31, 2017-$2.42M–
Q4 FY2016Dec 31, 2016-$2.76M–
Q3 FY2016Sep 30, 2016-$2.74M–

More Aspira Women's Health figures

See a number that looks wrong?